Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Frequently asked questions
What sector does Lotus Pharmaceutical Co Ltd (1795) operate in?
Lotus Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Lotus Pharmaceutical Co Ltd (1795) current stock price?
As of the latest data, Lotus Pharmaceutical Co Ltd stock price is NT$175.50, with a previous close of NT$177.50. Lotus Pharmaceutical Co Ltd lost -NT$2.00 in the last trading session, representing a -1.13% loss.
What is Lotus Pharmaceutical Co Ltd (1795) current market capitalization?
Lotus Pharmaceutical Co Ltd market cap is approximately 46.12 billion.
What is Lotus Pharmaceutical Co Ltd (1795) Earnings Per Share (EPS)?
The trailing EPS is NT$14.78, and the forward EPS is NT$25.20.
What is Lotus Pharmaceutical Co Ltd (1795) Price-to-Earnings (P/E) ratio?
Lotus Pharmaceutical Co Ltd current P/E ratio is 11.87, with a forward P/E of 6.96.
What is Lotus Pharmaceutical Co Ltd (1795) EBITDA?
Lotus Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.97 billion.
Does Lotus Pharmaceutical Co Ltd (1795) pay dividends?
No. Lotus Pharmaceutical Co Ltd does not pay a dividend.
How did Lotus Pharmaceutical Co Ltd (1795) perform in its most recent earnings report?
In the last report (June 30, 2026), Lotus Pharmaceutical Co Ltd posted an EPS surprise of 5.58% and a revenue surprise of 2.95%.
What is Lotus Pharmaceutical Co Ltd (1795) beta (volatility) score?
Lotus Pharmaceutical Co Ltd has a beta of 0.641, indicating lower volatility than the overall market.
